|
Inspection of Pacira Plant Prompts ‘Precautionary’ EU Recall of Cancer Drug DepoCyte
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use has urged Pacira Pharmaceuticals’ cancer drug DepoCyte be recalled in certain EU countries, citing “manufacturing deficiencies” found at the company’s San Diego, Calif., facility.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives